NVS · Novartis AG · Proposed Sales
$160.50
+0.25 (+0.16%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$303.12B
Shares
1.89B
Volume · Nov 13
1.42M
Avg daily vol (3M)
2.11M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-10-28 | Bulto Carulla Victor | Officer | 6,000 | 2026-10-28 | Fidelity Brokerage Services LLC |
| 2026-04-30 | Bulto Carulla Victor | Officer | 6,800 | 2026-04-30 | Fidelity Brokerage Services LLC |
| 2026-02-12 | Marshall Fiona | Officer | 30,743 | 2026-02-12 | Fidelity Brokerage Services LLC |
| 2026-02-09 | Bulto Carulla Victor | Officer | 7,500 | 2026-02-09 | Fidelity Brokerage Services LLC |
| 2025-05-23 | Marshall Fiona | Officer | 15,000 | 2025-05-23 | Fidelity Brokerage Services LLC |
| 2025-04-30 | Kowalski Robert William | Officer | 1,212 | 2025-04-30 | Fidelity Brokerage Services LLC |
| 2024-08-12 | Kowalski Robert William | Officer | 6,566 | 2024-08-12 | Fidelity Brokerage Services LLC |
| 2024-05-22 | Gal Aharon | Officer | 2,500 | 2024-05-22 | The Charles Schwab Corporation |
| 2023-09-19 | Kowalski Robert William | Officer | 1,581 | 2023-09-19 | Fidelity Brokerage Services LLC |
Showing 1–9 of 9 filings
Key facts
CIK
1114448
CUSIP
66987V109
13F (30d)
1276 filings
1161 filers
Visit website
Investor relations